Evidence map›Paper›PMID 39929794›Full record

ReviewCell death discovery2025

Insights on the crosstalk among different cell death mechanisms.

Georgette Eskander, Sherihan G Abdelhamid, Sara A Wahdan, Sara M Radwan

Abstract readReview
In one paragraph

Review in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Imaging the hallmarks of cancer.Nature reviews. Cancer · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Pyroptosis: Molecular mechanisms and function.Journal of physiology and biochemistry · 2026
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Role of Ferredoxin 1Cancer pathogenesis and therapy · 2026
    Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Georgette EskanderPostgraduate program, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.ORCID http://orcid.org/0000-0002-4872-2526
Sherihan G AbdelhamidBiochemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.ORCID http://orcid.org/0000-0003-4900-3715
Sara A WahdanPharmacology and toxicology Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Sara M RadwanBiochemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. sara.mostafa@pharma.asu.edu.eg.ORCID http://orcid.org/0000-0002-7994-093X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phenomenon of cell death has garnered significant scientific attention in recent years, emerging as a pivotal area of research. Recently, novel modalities of cellular death and the intricate interplay between them have been unveiled, offering insights into the pathogenesis of various diseases. This comprehensive review delves into the intricate molecular mechanisms, inducers, and inhibitors of the underlying prevalent forms of cell death, including apoptosis, autophagy, ferroptosis, necroptosis, mitophagy, and pyroptosis. Moreover, it elucidates the crosstalk and interconnection among the key pathways or molecular entities associated with these pathways, thereby paving the way for the identification of novel therapeutic targets, disease management strategies, and drug repurposing.

Identifiers

PMID39929794
PMCPMC11811070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.